Cover Image
市場調查報告書

全球經導管二尖瓣瓣膜修復、置換術(TMVR)市場:產業分析與預測

Global Transcatheter Mitral Valve Repair & Replacement (TMVR) Market: Industry Analysis & Outlook 2018-2022

出版商 Koncept Analytics 商品編碼 619840
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
全球經導管二尖瓣瓣膜修復、置換術(TMVR)市場:產業分析與預測 Global Transcatheter Mitral Valve Repair & Replacement (TMVR) Market: Industry Analysis & Outlook 2018-2022
出版日期: 2018年03月21日 內容資訊: 英文 76 Pages
簡介

本報告提供全球經導管帽僧閥修復、置換術(TMVR)市場調查,疾病及治療方法概要,全體、美國、歐洲的市場規模及患者數的變化與預測(過去5年、今後5年份),推動市場要素與阻礙要素以及課題分析,競爭情形,主要企業的簡介等系統性資訊。

第1章 概要

  • 帽僧閥逆流症(MR)
  • 傳統的治療方法
  • 經導管二尖瓣瓣膜修復、置換術(TMVR)
  • 經導管二尖瓣瓣膜修復、置換術(TMVR)的優點與風險

第2章 全球經導管二尖瓣瓣膜修復、置換術(TMVR)市場分析

  • 市場規模的預測
  • 市場分析:各地區
  • 市場預測(以數量為準)
  • 帽僧閥逆流症(MR)患者數
  • 帽僧閥逆流症(MR)患者數的預測
  • 接受手術的患者數的預測
  • 高風險MR患者數的預測

第3章 地區市場分析

  • 美國
  • 歐洲

第4章 市場動態

  • 促進因素
  • 市場趨勢
  • 課題

第5章 競爭情形

  • 全球市場

第6章 企業簡介

目錄

A human heart has four valves: Mitral valve, Tricuspid valve, Aortic valve and Pulmonary valve. Mitral valve is located on the left side of the heart and has two flaps which create a passage for oxygenated blood to travel from the left atrium to left ventricle. Mitral valve is attached by chordae tendinae to the papillary muscles which prevent the leaflets from prolapsing during ventricular contraction.

When the mitral valve does not close properly, then this condition is called Mitral Regurgitation. Mitral Regurgitation (MR) is a valve disorder where blood leaks backward through the mitral valve with heart contractions and reduces the amount of blood pumped through the body, which over time can lead to heart dysfunction and heart failure. Mitral Regurgitation can be of two types: Functional Mitral Regurgitation (FMR) and Degenerative Mitral Regurgitation (DMR).

Europe is a major contributor to the global TMVR market supported by increased ageing and obese population, better accessibility and favorable reimbursement policies for TMVR. The U.S. is also expecting a high growth rate in TMVR market due to rising development of TMVR devices and incidences of heart diseases.

The global TMVR market is expected to grow in future due to increasing ageing population, obese population, rising healthcare expenditure and economic growth. Key trends of this market include leading causes of death in the U.S., factors affecting the development of TMVR devices, prevalence of mitral regurgitation by age group in the U.S. and growing adoption of minimally invasive therapies. However, there are some factors which can hinder the market growth including associated high risks and tough regulatory problems.

The report "Global TMVR Market: Industry Analysis & Outlook (2018-2022)" by Koncept Analytics provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S., and Europe region along with the global market. The report profiles the key players of the market including Medtronic plc, Abbott Laboratories, Edwards and LivaNova Plc.

Table of Contents

1. Overview

  • 1.1 Mitral Regurgitation
  • 1.2 Traditional Surgical Method
  • 1.3 TMVR
  • 1.4 Benefits and Risk Associated with TMVR

2. Global TMVR Market Analysis

  • 2.1 TMVR Market Value Forecast
  • 2.2 TMVR Market by Region
  • 2.3 TMVR Market Volume Forecast
  • 2.4 MR Patient Population
  • 2.5 MR Patient Population Forecast
  • 2.6 Surgically Treated MR Patient Population Forecast
  • 2.7 High Risk MR Patient Population Forecast

3. Regional Market Analysis

  • 3.1 The U.S.
    • 3.1.1 The U.S. TMVR Market Value Forecast
    • 3.1.2 The U.S. TMVR Market Value Forecast by Type
    • 3.1.3 The U.S. TMVR Market Volume Forecast
    • 3.1.4 The U.S. TMVR Market Volume Forecast by Type
    • 3.1.5 The U.S. Mitral Regurgitation Patient Population
    • 3.1.6 The U.S. Mitral Regurgitation Patient Population Forecast
    • 3.1.7 The U.S. Surgically Treated MR Patient Population Forecast
    • 3.1.8 The U.S. High Risk MR Patient Population Forecast
  • 3.2 Europe
    • 3.2.1 Europe TMVR Market Value Forecast
    • 3.2.2 Europe TMVR Market Value Forecast by Type
    • 3.2.3 Europe TMVR Market Volume Forecast
    • 3.2.4 Europe TMVR Market Volume Forecast by Type
    • 3.2.5 Europe MR Patient Population
    • 3.2.6 Europe MR Patient Population Forecast
    • 3.2.7 Europe Surgically Treated MR Patient Population Forecast
    • 3.2.8 Europe High Risk MR Patient Population Forecast

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Growing Ageing Population
    • 4.1.2 Escalating Healthcare Spending
    • 4.1.3 Rising GDP Per Capita
    • 4.1.4 Increase in Obese Population
  • 4.2 Key Trends & Developments
    • 4.2.1 Leading Causes of Death in The U.S
    • 4.2.2 Factors Affecting the Development of TMVR Devices
    • 4.2.3 Prevalence of MR by Age Group in the U.S
    • 4.2.4 Growing Adoption of Minimally Invasive Therapies
  • 4.3 Challenges
    • 4.3.1 Associated High Risk
    • 4.3.2 Tough Regulatory Problems

5. Competition

  • 5.1 Global Market
    • 5.1.1 Key Competitors and Devices in the Global TMVR Market
    • 5.1.2 Revenue Comparison of Key Players
    • 5.1.3 Market Cap Comparison of Key Players

6. Company Profiles

  • 6.1 Medtronic Plc.
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 Abbott Laboratories
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Edwards Lifesciences
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 LivaNova Plc
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies

List of Charts

  • Types of Mitral Regurgitation
  • Global TMVR Market Value Forecast (2017-2022)
  • Global TMVR Market by Region (2017)
  • Global TMVR Market Volume Forecast (2017-2022)
  • Global MR Patient Population (2013-2017)
  • Global MR Patient Population Forecast (2018-2022)
  • Global Surgically Treated MR Patient Population Forecast (2017-2022)
  • Global High Risk MR Patient Population Forecast (2017-2022)
  • The U.S. TMVR Market Value Forecast (2017-2022)
  • The U.S. TMVR Market Value Forecast by Type (2017-2022)
  • The U.S. TMVR Market Volume Forecast (2017-2022)
  • The U.S. TMVR Market Volume Forecast by Type (2017-2022)
  • The U.S. Mitral Regurgitation Patient Population (2013-2017)
  • The U.S. Mitral Regurgitation Patient Population Forecast (2018-2022)
  • The U.S. Surgically Treated MR Patient Population Forecast (2017-2022)
  • The U.S. High Risk MR Patient Population Forecast (2017-2022)
  • Europe TMVR Market Value Forecast (2017-2022)
  • Europe TMVR Market Value Forecast by Type (2017-2022)
  • Europe TMVR Market Volume Forecast (2017-2022)
  • Europe TMVR Market Volume Forecast by Type (2017-2022)
  • Europe MR Patient Population (2013-2017)
  • Europe MR Patient Population Forecast (2018-2022)
  • Europe Surgically Treated MR Patient Population Forecast (2017-2022)
  • Europe High Risk MR Patient Population Forecast (2017-2022)
  • Global Ageing Population (2013-2017)
  • Global Healthcare Spending Per Capita (2013-2017)
  • Global GDP Per Capita (2013-2017)
  • Global Obese Population (2013-2017)
  • Most Common Causes of Death in the U.S. (2017)
  • Challenging Factors for TMVR Devices Development (2017)
  • The U.S. MR Prevalence by Age Group (2017)
  • Key Competitors and Their Devices (2017)
  • Revenue Comparison of Key Players (2017)
  • Market Cap Comparison of Key Players
  • Medtronic Plc. Revenue by Segments (2017)
  • Medtronic Plc. Net Sales and Net Income (2013-2017)
  • Abbott Laboratories Revenue by Segments (2017)
  • Abbott Laboratories Net Sales and Net Earnings (2013-2017)
  • Abbott Laboratories R&D Expenditure (2015-2017)
  • Edwards Lifesciences Corporation Revenue by Segments (2017)
  • Edwards Lifesciences Net Sales and Net Income (2013-2017)
  • Edwards Lifesciences R&D Expenditure (2015-2017)
  • LivaNova Plc Sales by Segment (2017)
  • LivaNova Plc. Net Sales and Net Income (2013-2017)
  • LivaNova Plc. R&D Expenditure (2015-2017)
Back to Top